Skip to main content
. 2020 Dec 4;10:568369. doi: 10.3389/fonc.2020.568369

Table 1.

Baseline characteristics of participants.

Variable Seizure after operation P value
Yes No
Age (years) at operation 0.526
 ≥60 10/54 44/54
 <60 30/132 102/132
Gender 0.638
 male 10/52 42/52
 female 30/134 104/134
Seizure before operation 0.090
 Yes 12/38 26/38
 No 28/148 120/148
The course of disease(years) 0.983
 <1 31/146 115/146
 1–5 6/27 21/27
 >5 3/13 10/13
Maximum cross-sectional area 0.579
 ≤15 23/114 91/114
 >15 17/72 55/72
Location of tumor 0.032
 non-skull base location 34/142 108/142
 skull base location 6/44 36/44
Multiple tumor 0.502
 Yes 3/10 7/10
 No 37/176 139/176
Adjacent to the cortex 0.150
 Yes 27/107 80/107
 No 13/79 66/79
Peritumoral brain edema 0.149
 Yes 27/108 81/108
 No 13/78 65/78
Hydrocephalus 0.003
 yes 7/13 6/13
 No 33/173 140/173
WHO classification 0.245
 I level 35/171 136/171
 II/III level 5/15 10/15
Peritumoral adhesion 0.774
 Yes 27/122 95/122
 No 13/64 51/64
AEDs 0.021
 no 7/80 73/80
 Prophylactic treatment 24/68 44/68
 Treatment for seizure attack before operation 9/38 29/38